• Sigrid Veasey.
• Center for Sleep & Respiratory Neurobiology & Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. veasey@mail.med.upenn.edu
• Indian J Med Res. 2010 Feb 1; 131: 236-44.

AbstractObstructive sleep apnoea (OSA) is a prevalent disorder with significant co-morbidities. Presently only rarely, treatments for obstructive sleep apnoea are curative. More typically, this is a disease that requires lifelong intervention and commitment from both the patients and healthcare providers. In light of the commitments, there is no uniform approach to treating sleep apnoea. Rather, approach to treatment of OSA should be governed by disease severity, symptoms and health risk and by which approach will work best for in a specific patient. It is equally important to identify and treat contributors to obstructive sleep apnoea severity, including obesity and endocrine disorders. In this sense, treating the patient with obstructive sleep apnoea requires a long-term partnership between patient and sleep medicine healthcare providers. With a strong partnership, obstructive sleep apnoea may be effectively treated in growing numbers of patients.

16 keywords...

hide…